Welcome to our dedicated page for ASTROTECH SEC filings (Ticker: ASTC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astrotech Corporation filings document an instrumentation company organized around subsidiaries applying mass spectrometry and gas chromatography to security screening, narcotics detection, agriculture processing, industrial process control, breath analysis, and environmental testing. Results-related 8-K reports include operating updates for product lines such as TRACER 1000 and EN-SCAN.
The filing record also covers security-holder rights under the company's rights agreement, annual meeting voting matters, executive compensation and governance disclosures in proxy materials, officer changes, consulting arrangements, and transaction-related compensation plans. These disclosures describe ASTC's capital structure, board oversight, compensation framework, and material-event reporting obligations.
ASTROTECH Corp (symbol: ASTC) is the issuer of record for a Form 4 filing submitted to the SEC.
Astrotech Corporation (ASTC) reported an update to its equity financing arrangements under its existing at-the-market offering agreement with H.C. Wainwright & Co., LLC. The company filed a new prospectus supplement under a recently effective shelf registration statement to permit the offer and sale of up to $50 million of common stock through at-the-market transactions, with Wainwright acting as sales agent. This new supplement replaces and supersedes the prior June 2026 prospectus supplement, under which Astrotech had been authorized to sell up to approximately $24.5 million of common stock. As of August 19, 2026, Astrotech had sold 258,856 shares of common stock for gross proceeds of approximately $7.9 million under the prior supplement, and no further sales will be made under that earlier document. A legal opinion from Haynes and Boone, LLP, covering the validity of the newly registered shares, is filed as an exhibit.
Astrotech Corporation (ASTC) is updating its at-the-market equity program, allowing it to issue and sell up to $50,000,000 of common stock from time to time through H.C. Wainwright & Co. as sales agent. The firm previously sold 258,856 shares under this agreement for about $7.9 million, and those sales are now fully covered by a prior prospectus supplement.
At an illustrative price of $7.94 per share, ASTC shows a scenario of issuing 6,038,373 new shares, which would increase shares outstanding from 2,107,596 to up to 8,145,969. Net proceeds are earmarked for general corporate purposes, with discretion retained by management. The company highlights highly speculative, early‑stage lunar infrastructure and mining “Initiatives” that would require substantial capital and face intense technical, regulatory and competitive risks, and notes a potential sale process for its 1st Detect subsidiary to help fund these plans.
Astrotech Corp. (ASTC) previously registered up to $24,492,819 of common stock for sale in an at-the-market program through H.C. Wainwright & Co. From June 3, 2026 to this supplement date, the company sold 258,856 shares for gross proceeds of approximately $7.9 million.
This supplement terminates the continuous offering under the June Prospectus effective August 19, 2026, and no further shares will be sold under that document. The at-the-market Offering Agreement remains in effect, and any future sales of common stock under it will be made pursuant to a new August 19, 2026 prospectus supplement to the company’s S-3 shelf, which covers up to $50 million of common stock.
Astrotech Corporation filed an amended quarterly report to correct the disclosed number of common shares issuable upon conversion of its Series D convertible preferred stock, now stating that 280,898 preferred shares convert on a one-for-thirty basis into approximately 9,363 common shares.
For the quarter ended March 31, 2026, revenue was $343 thousand, down from $534 thousand a year earlier, and gross margin declined to 20% as some high-cost consumables were sold below cost. Operating expenses were $3,520 thousand, resulting in a net loss of $3,768 thousand, and a nine-month net loss of $11,161 thousand on $787 thousand of revenue.
As of March 31, 2026, Astrotech held $2,679 thousand in cash and $3,903 thousand in short-term investments, with working capital of about $9.5 million. Management expects these resources, operating cash flows, and capital-raising activities to fund operations for at least 12 months and has a $30 million shelf registration (subject to a Baby Shelf Limitation) to preserve funding flexibility.
Badugu Nihanth reported acquisition or exercise transactions in this Form 4 filing.
Astrotech Corp reported that Chief Operating Officer Badugu Nihanth received a grant of 5,000 shares of restricted common stock under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. The award was recorded at 0.0000 per share and increases his directly held common stock to 5,000.0000 shares, subject to time-based vesting on anniversaries of August 13, 2026 until fully vested on August 13, 2028, contingent on continuous employment.
Astrotech Corporation expanded its Board of Directors and appointed Matt Kreps as a director, effective July 16, 2026. He will serve until the company’s 2026 annual meeting of stockholders and until a successor is elected and qualified or earlier departure. As of this appointment, he has not been assigned to any board committees.
Kreps, aged 49, brings more than 25 years of experience in capital markets and investor relations, including senior roles at HydroGraph Clean Power Inc. and Darrow Associates. Astrotech granted him 2,150 shares of restricted stock under its 2021 Omnibus Equity Incentive Plan, vesting in three equal annual installments. He will receive standard non-employee director compensation, and the company reports no related-party transactions or special arrangements tied to his appointment. A press release dated July 22, 2026 announced the move.
Halinski John William reported acquisition or exercise transactions in this Form 4 filing.
Astrotech Corp director John William Halinski received a grant of 1,055 shares of restricted Common Stock on July 9, 2026 under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan.
The company states that 100% of these restricted shares vested immediately on the grant date, bringing his directly held Common Stock position to 12,211 shares.
Winn Charles Arch reported acquisition or exercise transactions in this Form 4 filing.
Astrotech Corp director Winn Charles Arch received an equity award. On 2026-07-09 he was granted 1,055 shares of restricted common stock under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan, which vested immediately. Following the grant he directly held 10,950 common shares, including 485 held in his IRA.
MCFARLAND ROBERT N reported acquisition or exercise transactions in this Form 4 filing.
Astrotech Corp director Robert N. McFarland received a grant of 1,055 shares of restricted common stock on July 9, 2026 under the Astrotech Corporation 2021 Omnibus Equity Incentive Plan. The award vested 100% immediately on the grant date, increasing his directly held common shares to 11,205.